Skip to content
Open access

Associations of General and Central Obesity with Cardiovascular Risk by Menopausal and MASLD Status

Sep 2026 · Biomedicines · Vol 14, pp. 1985 · 0 citations · 44 references
Medicine

TL;DR

Associations with obesity phenotype varied by menopausal status: general obesity was associated with risk in premenopausal women without MASLD, whereas after menopause the association was more consistent for central obesity.

Abstract

Background/Objectives: Metabolic dysfunction-associated steatotic liver disease (MASLD) prevalence increases during the menopausal transition, yet its interaction with obesity phenotypes in influencing cardiovascular disease (CVD) risk remains unclear. We examined how MASLD and obesity types are associated with CVD risk in pre- and postmenopausal women. Methods: This nationwide cohort analyzed 1,959,367 Korean women aged ≥40 years (848,672 premenopausal, 1,110,695 postmenopausal) followed for a median of 12.3 years. MASLD was defined by the fatty liver index plus ≥1 cardiometabolic risk factor and alcohol intake <20 g/day. General obesity was defined as body mass index ≥25 kg/m2 and central obesity as waist circumference ≥85 cm. Results: During follow-up, 106,792 women (5.45%) developed CVD. MASLD was associated with higher CVD risk regardless of menopausal status, though the association was numerically smaller in postmenopausal women. Among women without MASLD, general obesity was associated with risk before menopause (adjusted hazard ratio [aHR] 1.10, 95% confidence interval [CI] 1.04–1.17; central obesity, aHR 1.06, 95% CI 0.96–1.18), whereas after menopause central obesity was associated with risk (aHR 1.08, 95% CI 1.05–1.10). In postmenopausal women with MASLD, the estimate for general obesity was inverse (aHR 0.95) while central obesity remained positively associated (aHR 1.05); in an exploratory sensitivity analysis using an anthropometry-free metabolic proxy (the triglyceride–glucose index), the inverse estimate was not reproduced (aHR 1.06). Conclusions: MASLD was associated with elevated CVD risk across menopausal stages. Associations with obesity phenotype varied by menopausal status: general obesity was associated with risk in premenopausal women without MASLD, whereas after menopause the association was more consistent for central obesity. These are observational contrasts between groups that also differ substantially in age and should not be interpreted causally. They may nonetheless inform prevention tailored to menopausal stage, MASLD status, and obesity phenotype.

Read PDF

Similar papers

Open access Aug 2026

Lifestyle mediates the association between normal-weight visceral obesity and MASLD in older adults with hypertension and diabetes

Objective Older adults with coexisting hypertension and type 2 diabetes are at high risk for metabolic dysfunction-associated steatotic liver disease (MASLD). Normal-weight visceral obesity (NWVO)—excess visceral fat despite normal body mass index and waist circumference—is an overlooked risk factor. Lifestyle is modif...

Jun-Yan Xi, Yi-Jing Wang, Xiao-Heng Li et al. · 0 citations
Open access Sep 2026

Reproductive Characteristics, Postmenopausal Obesity, and Cardiovascular Disease Incidence in the Women's Health Initiative

Background Early menarche, menopause, and short reproductive lifespan are risk factors for cardiovascular disease (CVD), but whether these reproductive characteristics are independently associated with CVD or influenced by obesity is unclear. This study aimed to address this gap. Methods Postmenopausal women from the W...

J. Borrowman, Hailey R. Banack, C. Cook et al. · 1 citation · ⚡1
Open access Aug 2026

Adiposity and risk of breast cancer in 280 000 Chinese women: a prospective cohort study

Higher levels of general and central adiposity were associated with a higher risk of breast cancer, in both women who were premenopausal and women who were post-menopausal at baseline in this cohort of Chinese women.

C. Kartsonaki, N. Wright, I. Millwood et al. · 0 citations
Open access Oct 2026

Residual Atherogenic Dyslipidemia in Normal-Weight Adults: The Role of Visceral Adiposity and Metabolic Dysfunction

Background. Body mass index (BMI) remains the most widely used tool for obesity classification and cardiometabolic risk stratification. However, increasing evidence suggests that normal BMI does not necessarily reflect metabolic health, particularly in individuals with hidden visceral adiposity and residual atherogenic...

Diego Andrés González Carrasco, P. T. Tárraga López, Mónica Silu Piña Dabreu et al. · 0 citations
Open access Oct 2026

The association between androgenic profile and cardiometabolic risk factors in young men: insights from a large observational cohort study.

PURPOSE The current single-center, retrospective, observational cohort study with a cross-sectional design was conducted to evaluate the association between androgenic profile and metabolic cardiovascular risk (mCVR) factors and to explore whether testosterone deficiency was associated with an unfavourable cardiometabo...

D. Menafra, C. de Angelis, F. Garifalos et al. · 0 citations
Open access Sep 2026

Body fat distribution, lipid profile and cardiometabolic risk factors in perimenopause

Background: Body fat correlates with increased risks of metabolic and cardiovascular diseases, Young women are at a heightened risk for metabolic syndrome linked to dyslipidemia, which contributes to atherosclerosis. Objective: The aimed of study is correlation between body fat distribution, lipid profiles, and cardiom...

Rosdiana Mus, Elpira Asmin, Ingrid A. Hutagalung et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.